A Study of an Oral Nutritional Supplement in a Malnourished Population With GI Tolerance Impairment
Launched by ABBOTT NUTRITION · Feb 29, 2016
Trial Information
Current as of June 17, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subject is considered malnourished, or is at risk for malnutrition based on MUST score ≥2.
- • Subject is ≥18 years old.
- • Subject has a condition that would benefit from a high calorie, higher protein ONS for GI tolerance impairment (e.g., diarrhea, nausea, vomiting, satiety or bloating).
- • Subject conforms to the requirements set forth on the study product label.
- • Subject is under the care of a health care professional for malnutrition and has recently (within the last 7 days prior to participating in this study) been prescribed 2 servings/day of the study ONS. Subject must have been naïve to ONS for GI tolerance impairment prior to being prescribed the study ONS.
- Exclusion Criteria:
- • The study physician determines the subject is not fit to participate
- • Subject cannot provide informed consent to participate in the study.
- • Subject cannot safely consume the oral nutritional supplement.
- • Renal or liver failure (GFR\< 60 ml/min or AST/ALTx3 normal) upper limit.
- • Type 1 or type 2 diabetes.
About Abbott Nutrition
Abbott Nutrition, a division of Abbott Laboratories, is a global leader in pediatric and adult nutrition, dedicated to advancing nutritional science and improving health outcomes through innovative products and research. With a commitment to evidence-based practices, Abbott Nutrition conducts rigorous clinical trials to evaluate the safety, efficacy, and nutritional benefits of its offerings. The organization collaborates with healthcare professionals and researchers worldwide to enhance understanding of nutritional needs and develop solutions tailored to diverse populations. Through its focus on quality, innovation, and scientific integrity, Abbott Nutrition strives to support healthier lives across all stages of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Zaragoza, , Spain
Badalona, , Spain
Madrid, , Spain
Sevilla, , Spain
Barakaldo, , Spain
Barakaldo, , Spain
Cadiz, , Spain
Córdoba, , Spain
Granada, , Spain
Leon, , Spain
Madrid, , Spain
Madrid, , Spain
Marbella, , Spain
Marbella, , Spain
Murcia, , Spain
Málaga, , Spain
Móstoles, , Spain
Orihuela, , Spain
Ponferrada, , Spain
Valencia, , Spain
Valencia, , Spain
Vic, , Spain
Patients applied
Trial Officials
Rebecca Sanz Barriuso, RD, PharmD
Study Chair
Abbott Nutrition
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials